SPHK1 and pulmonary arterial hypertension: Our previous studies showed that SPHK1 was upregulated in PASMCs isolated from patients with PAH and that the genetic deletion of Sphk1 in mice or the pharmacological inhibition of SPHK1 activity reduced hypoxia-induced pulmonary hypertension (PH) in mice and rats [4].